David Grimwade

31.8k total citations · 7 hit papers
152 papers, 15.6k citations indexed

About

David Grimwade is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Grimwade has authored 152 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hematology, 111 papers in Molecular Biology and 47 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Grimwade's work include Acute Myeloid Leukemia Research (118 papers), Retinoids in leukemia and cellular processes (87 papers) and Acute Lymphoblastic Leukemia research (47 papers). David Grimwade is often cited by papers focused on Acute Myeloid Leukemia Research (118 papers), Retinoids in leukemia and cellular processes (87 papers) and Acute Lymphoblastic Leukemia research (47 papers). David Grimwade collaborates with scholars based in United Kingdom, United States and France. David Grimwade's co-authors include Alan K. Burnett, Keith Wheatley, Robert K. Hills, Christine J. Harrison, Helen M. Walker, Anthony P. Goldstone, Ian Hann, Anthony H. Goldstone, Sylvie Freeman and Fiona Oliver and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David Grimwade

150 papers receiving 15.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

2009 2.4k citations Hartmut Döhner, Elihu H. Estey et al. Blood profile →
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

1998 2.1k citations David Grimwade, Helen M. Walker et al. Blood profile →
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

2010 1.3k citations David Grimwade, Robert K. Hills et al. Blood profile →
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

2003 1.1k citations David Grimwade, Giuseppe Saglio et al. Leukemia profile →
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

2001 710 citations David Grimwade Blood profile →
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

2008 605 citations Miguel Á. Sanz, David Grimwade et al. Blood profile →
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

2015 346 citations Alan K. Burnett, Nigel H. Russell et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Grimwade United Kingdom	50	12.7k	8.4k	4.5k	3.0k	1.8k	152	15.6k
Francesco Lo‐Coco Italy	58	11.2k 0.9×	11.3k 1.3×	3.4k 0.8×	2.6k 0.9×	2.7k 1.6×	276	18.0k
Elisabeth Paietta United States	61	7.8k 0.6×	4.7k 0.6×	4.3k 1.0×	2.6k 0.9×	3.0k 1.7×	278	12.9k
Sylvie Castaigné France	46	6.0k 0.5×	5.1k 0.6×	1.5k 0.3×	1.5k 0.5×	2.1k 1.2×	168	9.2k
Hitoshi Kiyoi Japan	46	5.4k 0.4×	4.4k 0.5×	1.4k 0.3×	2.0k 0.7×	2.1k 1.2×	277	9.0k
Nigel H. Russell United Kingdom	57	8.9k 0.7×	4.4k 0.5×	2.5k 0.6×	2.5k 0.9×	3.3k 1.9×	355	12.4k
Gautam Borthakur United States	65	13.2k 1.0×	6.7k 0.8×	3.3k 0.7×	6.5k 2.2×	2.9k 1.7×	809	17.7k
Eva Hellström‐Lindberg Sweden	40	8.2k 0.6×	4.0k 0.5×	1.4k 0.3×	3.8k 1.3×	1.2k 0.7×	187	10.6k
Susana C. Raimondi United States	62	9.4k 0.7×	5.6k 0.7×	8.1k 1.8×	1.7k 0.6×	2.5k 1.4×	259	15.3k
Tapan M. Kadia United States	57	9.8k 0.8×	5.4k 0.6×	3.0k 0.7×	3.9k 1.3×	2.7k 1.5×	778	13.2k
Uwe Platzbecker Germany	54	8.8k 0.7×	3.6k 0.4×	1.6k 0.4×	4.1k 1.4×	1.7k 1.0×	543	11.3k

Countries citing papers authored by David Grimwade

Since Specialization

Citations

This map shows the geographic impact of David Grimwade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grimwade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grimwade more than expected).

Fields of papers citing papers by David Grimwade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Grimwade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grimwade. The network helps show where David Grimwade may publish in the future.

Co-authorship network of co-authors of David Grimwade

This figure shows the co-authorship network connecting the top 25 collaborators of David Grimwade. A scholar is included among the top collaborators of David Grimwade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Grimwade. David Grimwade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grimwade, David, Adam Ivey, & Brian J.P. Huntly. (2015). Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 127(1). 29–41. 292 indexed citations

Burnett, Alan K., Nigel H. Russell, Robert K. Hills, et al.. (2015). Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. The Lancet Oncology. 16(13). 1295–1305. 346 indexed citations breakdown →

Vyas, Paresh, Charlotte Bradbury, Peter Richardson, et al.. (2013). COMBINED ANALYSES OF ROS, CELL CYCLE AND IMMUNOPHENOTYPE SHOWS THAT NORMAL HEMATOPOIETIC PROGENITOR SUBSETS HAVE A DIFFERENTIAL ROS PROFILE THAT IS LOST IN ACUTE MYELOID LEUKEMIA. Haematologica. 98. 12–12. 1 indexed citations

Burnett, Alan K., Robert K. Hills, David Grimwade, et al.. (2012). Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. Leukemia. 27(4). 843–851. 53 indexed citations

Grimwade, David, Robert K. Hills, Anthony V. Moorman, et al.. (2010). Refinement of cytogenetic classification in acute myeloid leukaemia: Determination of prognostic significance of rarer recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials. British Journal of Haematology. 149. 17–17. 29 indexed citations

Grimwade, David, Robert K. Hills, Anthony V. Moorman, et al.. (2009). REFINEMENT OF CYTOGENETIC CLASSIFICATION IN AML: DETERMINATION OF PROGNOSTIC SIGNIFICANCE OF RARE RECURRING CHROMOSOMAL ABNORMALITIES AMONGST 5635 YOUNGER ADULTS TREATED IN THE UK MRC TRIALS. Haematologica. 94. 217–217. 5 indexed citations

Döhner, Hartmut, Elihu H. Estey, Sergio Amadori, et al.. (2009). Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 115(3). 453–474. 2350 indexed citations breakdown →

Jovanović, Jelena, J Score, Katherine Waghorn, et al.. (2006). Abstracts. British Journal of Haematology. 133(S1). 1–121. 3 indexed citations

Grimwade, David, Anthony V. Moorman, Robert K. Hills, et al.. (2004). Impact of karyotype on treatment outcome in acute myeloid leukemia.. Annals of Hematology. 83. 17 indexed citations

10.

Harrison, Christine J., Anthony V. Moorman, Robert K. Hills, et al.. (2003). Cytogenetics of childhood AML from UK medical research council treatment trials, AML10 & 12.. Blood. 102(11). 333–333. 3 indexed citations

11.

Grimwade, David, R P Gale, Robert K. Hills, et al.. (2003). The relationship between FLT3 mutation status: biological characteristics and outcome in patients with acute promyelocytic leukaemia.. Blood. 102(11). 3 indexed citations

12.

Grimwade, David, S Chatters, Christine J. Harrison, et al.. (2002). Refinement of cytogenetic classification in AML: determination of prognostic significance of rare recurring chromosomal abnormalities amongst patients entered into the UK MRC AML 10 & 12 trials.. Blood. 100(11). 3 indexed citations

13.

Tischkowitz, Marc, Neil V. Morgan, S V Hodgson, et al.. (2001). Mutation analysis of the Fanconi Anaemia group A, C, E, F and G genes in sporadic acute myeloid leukaemia. Journal of Medical Genetics. 38.

14.

Guidez, Fabien, Lucia Altucci, Ke Xu, et al.. (2001). Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement.. Blood. 98(11). 3 indexed citations

15.

Grimwade, David, Antonio Biondi, Julien Mozziconacci, et al.. (2000). Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Francais de Cytogenetique Hematologique, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". SPIRE - Sciences Po Institutional REpository. 30 indexed citations

16.

Grimwade, David, et al.. (1999). The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.. British Journal of Haematology. 105. 67–67. 5 indexed citations

17.

Grimwade, David, Daniela Diverio, G Harrison, et al.. (1999). Detection of minimal residual disease (MRD) in APL by "real-time" RT-PCR: Analysis of cases entered into the UK MRC ATRA trial.. Blood. 94(10). 8 indexed citations

18.

Sainty, Danielle, A Cantù-Rajnoldi, David Head, et al.. (1998). Morphological presentation of acute promyelocytic leukemia (APL) lacking the classical t(15;17) with special reference to a series of 9 cases with t(11;17). Blood. 92(10). 3 indexed citations

19.

Grimwade, David, Stephen E. Langabeer, Kathy Howe, et al.. (1998). The role of molecular diagnosis & residual disease monitoring in APL: Results of the MRC ATRA trial. British Journal of Haematology. 101. 103–103. 2 indexed citations

20.

Grimwade, David, Keith Wheatley, G Harrison, et al.. (1996). Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.. Blood. 88. 2525–2525. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact